American Society of Hematology, Blood, 2(131), p. 202-214
DOI: 10.1182/blood-2017-06-790204
Full text: Unavailable
Key Points CD34+ progenitor-derived NK cells and HMAs potently cooperate against AML cells. DAC-mediated modulation of CD34-derived NK cell phenotype, function, and trafficking results in enhanced anti-leukemic effect in vivo.